Sign In
Buy BCS
$24.69
-0.590 (-2.33%)
At Close: Jun 03, 2026
Former Barclays CEO Jes Staley slept with Epstein assistant, court hears
02:17pm, Wednesday, 12'th Mar 2025
Former Barclays boss Jes Staley had sex with a member of serial paedophile Jeffrey Epstein's staff, the banker told a court on the third day of his evidence as he appeals against a proposed financial
'Too early to tell' if travel sector facing downturn, says Barclays
08:08am, Wednesday, 12'th Mar 2025
Following a sell-off of London-listed hotels and leisure stocks, including British Airways owner International Consolidated Airlines Group SA (LSE:IAG), analysts at Barclays said they remain cautious
Ex-Barclays CEO Staley says he had no idea of Epstein's 'monstrous activities'
09:04am, Tuesday, 11'th Mar 2025
Ex-Barclays boss Jes Staley said on Tuesday he had no idea about serial paedophile Jeffrey Epstein's "monstrous activities", as he gave evidence to try to overturn a finance industry ban over his rela
Barclays Chair told FCA Epstein-Staley ties did not need board review in 2019
12:27pm, Monday, 10'th Mar 2025
Barclays chairman Nigel Higgins believed the bank's former CEO Jes Staley's ties with the late disgraced financier Jeffrey Epstein did not warrant a board discussion in the summer of 2019 after Britai
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference
08:30am, Friday, 07'th Mar 2025
SEATTLE and VANCOUVER, British Columbia, March 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development
Enforcement of tariffs would 'eradicate profits' of automakers, says Barclays' Dan Levy
01:00pm, Thursday, 06'th Mar 2025
Dan Levy, Barclays senior equity research analyst, joins CNBC's 'Squawk on the Street' to discuss how potential tariffs could impact U.S. auto companies.
Barclays Shares Hit a 5-Year High: Is BCS Worth Betting on?
09:25am, Thursday, 06'th Mar 2025
Barclays stock hits a new 5-year high. Is now the perfect time to buy it, or should you wait for a dip?
Barclays reportedly to pay out millions to customers over outages
06:51am, Thursday, 06'th Mar 2025
Barclays PLC is reportedly gearing up to pay out millions of pounds in compensation to customers over recent online banking outages. Some £5 million to £7.5 million was expected to be paid for “in
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
05:30pm, Wednesday, 05'th Mar 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will prov
Puma Biotechnology to Present at Barclays Annual Global Healthcare Conference
04:11pm, Wednesday, 05'th Mar 2025
LOS ANGELES--(BUSINESS WIRE)--Alan Auerbach will provide an overview of Puma Biotechnology at the Barclays Annual Global Healthcare Conference at 2:00 p.m. ET on March 11.
Phibro Animal Health Corporation to Participate at Barclays Annual Global Healthcare Conference
04:00pm, Wednesday, 05'th Mar 2025
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Annual Global Healthcare Conference. Chief Financial Officer, Glenn
BCS or HDB: Which Is the Better Value Stock Right Now?
12:40pm, Wednesday, 05'th Mar 2025
Investors looking for stocks in the Banks - Foreign sector might want to consider either Barclays (BCS) or HDFC Bank (HDB). But which of these two companies is the best option for those looking for un
CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference
08:00am, Wednesday, 05'th Mar 2025
SOUTH SAN FRANCISCO, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean
Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference
07:30am, Wednesday, 05'th Mar 2025
WILMINGTON, Del., March 05, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will part
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
06:00am, Wednesday, 05'th Mar 2025
RANCHO CUCAMONGA, CA / ACCESS Newswire / March 5, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Oper
